Tirzepatide, (an active ingredient of the brand name Mounjaro) is an anti-diabetic medication used in treating type two diabetes and off-label use for obesity by inducing weight loss and lowering postprandial glucose concentration. Tirzepatide subcutaneous injection is used once a week for the treatment of obesity.
Tirzepatide treats diabetes and induces weight loss by the following mechanism:
Tirzepatide is contraindicated in patients with:
The Package Starting at $500 per vial Includes:
If you are struggling with obesity, we invite you to schedule a consultation with our team to learn more about our approach to treatment and how we can help you achieve your weight loss goals. We look forward to partnering with you on your journey to better health.
Copyright © 2022 Virginia Online Evaluations LLC/Soma Vita Wellness - All Rights Reserved.
Powered by GoDaddy